Rafarma Pharmaceuticals, Inc. (RAFA)
USD 0.11
(-23.17%)
USD 0.11
(-23.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.13 Million | 64.31 Million | 77.41 Million | 74.73 Million | 11.44 Million | 147.2 Thousand |
| Cost of Revenue | 9.53 Million | 41.5 Million | 50.14 Million | 41.64 Million | 8.08 Million | 143.59 Thousand |
| Gross Profit | 600 Thousand | 22.81 Million | 27.27 Million | 33.08 Million | 3.35 Million | 3612.00 |
| Operating Expenses | 287 Thousand | 15.66 Million | 12.54 Million | 14 Million | 262.09 Thousand | 9197.00 |
| Selling, General and Administrative Expenses | 150 Thousand | 5.41 Million | 5.35 Million | 8.1 Million | - | 9197.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 137 Thousand | -10.24 Million | -7.18 Million | -5.9 Million | -262.09 Thousand | - |
| Cost and Expenses | 9.82 Million | 57.16 Million | 62.68 Million | 55.64 Million | 8.34 Million | 152.78 Thousand |
| Operating Income | 313 Thousand | 7.15 Million | 14.72 Million | 19.08 Million | 3.09 Million | -5580.00 |
| Interest Expense | - | - | - | 7000.00 | 39.38 Thousand | 595.00 |
| Income Tax Expense | 87 Thousand | 1.26 Million | 3.01 Million | 3.71 Million | - | 4.00 |
| Earnings before Tax | 360 Thousand | 6.22 Million | 14.58 Million | 18.56 Million | 3.05 Million | -6179.00 |
| Net Income | 273 Thousand | 4.96 Million | 11.57 Million | 14.84 Million | 3.05 Million | -6179.00 |
| Earnings Per Share Basic | 0.00 | 0.06 | 0.13 | 0.17 | 0.03 | -0.00 |
| Earnings Per Share Diluted | 0.00 | 0.06 | 0.13 | 0.17 | 0.03 | -0.00 |
| Weighted Average Shares Outstanding | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 93.16 Million | 83.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 93.16 Million | 83.86 Million |
| Gross Margin | 0.06 | 0.35 | 0.35 | 0.44 | 0.29 | 0.02 |
| EBIT Margin | 0.03 | 0.11 | 0.19 | 0.26 | 0.31 | -0.04 |
| Profit Margin | 0.03 | 0.08 | 0.15 | 0.20 | 0.27 | -0.04 |
| EBITDA | 313 Thousand | 6.22 Million | 14.72 Million | 19.08 Million | 3.55 Million | -5584.00 |
| Earnings Before Tax Margin | 0.03 | 0.11 | 0.19 | 0.26 | 0.27 | -0.04 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 108 Thousand | 220 Thousand | 10.13 Million | 5.67 Million | 10.87 Million | 10.1 Million |
| Cost of Revenue | 47 Thousand | 147 Thousand | 9.53 Million | 4.06 Million | 6.29 Million | 6.17 Million |
| Gross Profit | 61 Thousand | 73 Thousand | 600 Thousand | 1.61 Million | 4.58 Million | 3.92 Million |
| Operating Expenses | 34 Thousand | 42 Thousand | 287 Thousand | 2.23 Million | 2.61 Million | 3.37 Million |
| Selling, General and Administrative Expenses | 13 Thousand | 12 Thousand | - | 706 Thousand | 891 Thousand | 971 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -21 Thousand | -30 Thousand | -137 Thousand | -1.53 Million | -1.72 Million | -2.39 Million |
| Cost and Expenses | 81 Thousand | 189 Thousand | 9.82 Million | 6.3 Million | 8.9 Million | 9.54 Million |
| Operating Income | 27 Thousand | 31 Thousand | 313 Thousand | -622 Thousand | 1.96 Million | 558 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -43.81 Thousand | 87 Thousand | -173 Thousand | 399 Thousand | 78 Thousand |
| Earnings before Tax | 17 Thousand | 34 Thousand | 360 Thousand | -1.02 Million | 2.17 Million | 105 Thousand |
| Net Income | 17 Thousand | 34 Thousand | 273 Thousand | -856 Thousand | 1.77 Million | 27 Thousand |
| Earnings Per Share Basic | 0.00 | 0.00 | - | -0.01 | 0.02 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | - | -0.01 | 0.02 | 0.00 |
| Weighted Average Shares Outstanding | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million | 87.76 Million |
| Gross Margin | 0.56 | 0.33 | 0.06 | 0.28 | 0.42 | 0.39 |
| EBIT Margin | 0.25 | 0.14 | - | -0.11 | 0.18 | 0.06 |
| Profit Margin | 0.16 | 0.15 | 0.03 | -0.15 | 0.16 | 0.00 |
| EBITDA | 27 Thousand | 31 Thousand | - | -622 Thousand | 1.96 Million | 558 Thousand |
| Earnings Before Tax Margin | 0.25 | 0.14 | 0.03 | -0.11 | 0.18 | 0.06 |
SHESHAINDS
ELT
7987
BEEYU
JTBK
DIVISLAB